Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Slideshows|February 21, 2019
Diabetes Drugs and Cardioprotection: 8 Questions on Key Trials
Author(s)Grace Halsey
Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.
Advertisement
Advertisement
Related to this article
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
Advertisement
Advertisement
Trending on Patient Care Online
1
Mediterranean Diet Linked to Lower Odds of Adult Acne in New Study
2
4 FDA Decisions for Primary Care to Know from October 2026
3
Why a Negative Endometrial Biopsy May Not End the Abnormal Bleeding Workup
4
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
5